脓毒症幸存者临床亚型的识别及其与不同一年结局的关系:FROG-ICU队列的二次潜在类别分析
本研究为FROG-ICU前瞻性、观察性、多中心研究的二次潜在类别分析。入组ICU入院时脓毒症(Sepsis-3)患者655例,其中467例存活出院并纳入分析。采用ICU出院时15项常规临床和生物学变量进行潜在类别分析,识别出两个亚型(A和B)。亚型B占48%,心血管和肾脏功能受损更重、血液学异常和炎症更明显;亚型B一年死亡率显著高于亚型A(34% vs 16%,p<0.001),校正标准长期风险因素后亚型B仍独立关联一年死亡率升高(校正HR=1.74,95%CI 1.16-2.60;p=0.006)。
要点
- ICU出院时用15项常规临床和生物学变量可将脓毒症幸存者分为两个亚型(A和B),亚型B占48%。
- 亚型B在ICU出院时心血管和肾脏功能受损更重、血液学异常和炎症更明显。
- 亚型B一年死亡率显著高于亚型A(34% vs 16%,p<0.001)。
- 校正年龄、合并症、疾病严重程度、肾功能和ICU住院时长后,亚型B仍独立关联一年死亡率升高(校正HR=1.74,95%CI 1.16-2.60;p=0.006)。
适用人群与场景
- FROG-ICU前瞻性、观察性、多中心研究中ICU入院时脓毒症(Sepsis-3)患者655例,其中467例存活出院并纳入本分析。
研究设计与关键结果
- 研究类型:FROG-ICU前瞻性、观察性、多中心研究的二次潜在类别分析;样本量655例脓毒症患者,其中467例ICU存活出院者纳入分析。
- 采用ICU出院时15项常规临床和生物学变量进行潜在类别分析,识别出两个亚型(A和B),亚型B占研究人群的48%。
- 亚型B在ICU出院时心血管和肾脏功能受损更重、血液学异常和炎症更明显。
- 主要终点一年死亡率:亚型B 34% vs 亚型A 16%(p<0.001)。
- 校正标准长期风险因素(如年龄、合并症、疾病严重程度、肾功能和ICU住院时长)后,亚型B独立关联一年死亡率升高(校正HR=1.74,95%CI 1.16-2.60;p=0.006)。
证据类型、等级与局限
- 证据类型:前瞻性、观察性、多中心研究的二次潜在类别分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,ICU出院时存在持续器官衰竭和炎症的亚型可从常规临床和实验室数据中识别,并独立关联脓毒症幸存者的不良长期结局。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Late mortality risk in sepsis-survivors persists for years with high readmission rates and low quality of life. The present study seeks to link the clinical sepsis-survivors heterogeneity with distinct biological profiles at ICU discharge and late adverse events using an unsupervised analysis.
METHODS: In the original FROG-ICU prospective, observational, multicenter study, intensive care unit (ICU) patients with sepsis on admission (Sepsis-3) were identified (N = 655). Among them, 467 were discharged alive from the ICU and included in the current study. Latent class analysis was applied to identify distinct sepsis-survivors clinical classes using readily available data at ICU discharge. The primary endpoint was one-year mortality after ICU discharge.
RESULTS: At ICU discharge, two distinct subtypes were identified (A and B) using 15 readily available clinical and biological variables. Patients assigned to subtype B (48% of the studied population) had more impaired cardiovascular and kidney functions, hematological disorders and inflammation at ICU discharge than subtype A. Sepsis-survivors in subtype B had significantly higher one-year mortality compared to subtype A (respectively, 34% vs 16%, p < 0.001). When adjusted for standard long-term risk factors (e.g., age, comorbidities, severity of illness, renal function and duration of ICU stay), subtype B was independently associated with increased one-year mortality (adjusted hazard ratio (HR) = 1.74 (95% CI 1.16-2.60); p = 0.006).
CONCLUSIONS: A subtype with sustained organ failure and inflammation at ICU discharge can be identified from routine clinical and laboratory data and is independently associated with poor long-term outcome in sepsis-survivors. Trial registration NCT01367093; https://clinicaltrials.gov/ct2/show/NCT01367093 .
参考来源
- Soussi S, Sharma D, Jüni P, et al. Identifying clinical subtypes in sepsis-survivors with different one-year outcomes: a secondary latent class analysis of the FROG-ICU cohort. Crit Care. 2022. PMID: 35449071. doi:10.1186/s13054-022-03972-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。